Andrew Wolfe sells 5,193 TBCH shares for $67.6K
Andrew Wolfe reported a sale of 5,193 shares of Common Stock on 06/03/2026 under a Form 144 submission.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Andrew Wolfe reported a sale of 5,193 shares of Common Stock on 06/03/2026 under a Form 144 submission. The filing shows cash proceeds of $67,606.11. The report also lists prior restricted stock grants dated 04/01/2024 (4,088 shares) and 04/01/2025 (6,988 shares).
Insights
Routine issuer-share disposition by an individual filing Form 144; transaction appears administrative.
The filing records a reported disposition of 5,193 shares by Andrew Wolfe on 06/03/2026 for $67,606.11. The entry is a standard Form 144 disclosure required when restricted or control securities are sold and does not itself state the method of sale or any 10b5-1 plan.
Referenced restricted stock grants of 4,088 (04/01/2024) and 6,988 (04/01/2025) are listed; the filing does not tie those grants directly to the sale proceeds or state remaining holdings. Cash-flow treatment and timing beyond the sale date are not detailed in the excerpt.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock financial
Issuer regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Andrew Wolfe report in the Form 144 for TBCH?
How much cash was reported from the sale in TBCH's Form 144?
Are the referenced restricted stock grants part of the reported sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.